Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.
about
A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment.Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?Modelling chemotherapy effects on granulopoiesis.Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.Treatment of the elderly patient with diffuse large B cell lymphoma.Potential pharmacological interventions against hematotoxicity: an overview.Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients.A prospectively validated nomogram for predicting the risk of chemotherapy-induced febrile neutropenia: a multicenter study.Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.Comparison and modelling of pegylated or unpegylated G-CSF schedules in CHOP-14 regimen of elderly patients with aggressive B-cell lymphoma.
P2860
Q33712928-A8354165-A062-4A5D-AE36-7FE7171F8FB9Q33756369-69494B61-ABDD-4648-B3B7-1C03B5AE5DF3Q34996295-1A10B307-F505-4A87-B68F-9E83E5ACC9CDQ36427261-7547711E-F63F-4765-974A-B4B31BF51D24Q37703409-2E5ECECE-E3D6-4F59-8749-7C533BF69676Q37998553-D1DB48FE-3153-4086-8611-D948866DB23EQ38406172-8BAE8EBF-6834-455F-8825-735D9FCFE52AQ39779938-9A608495-1A00-4311-9B3E-23E4F28BF9DBQ40180945-451C86DB-5395-4AB2-A26E-877C26F7420BQ46029514-7731F22A-4956-484C-BB54-0D15327839E9Q47616700-DA486595-2414-42E6-9BDF-7D8CEBABEA8FQ47657705-47F7F0B5-8D08-4CB0-8E3C-243EEFD532FAQ47918300-520CF6D3-21AE-4C7E-9E91-AA3021699E82
P2860
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prognostic factors for hematot ...... essive non-Hodgkin's lymphoma.
@ast
Prognostic factors for hematot ...... essive non-Hodgkin's lymphoma.
@en
type
label
Prognostic factors for hematot ...... essive non-Hodgkin's lymphoma.
@ast
Prognostic factors for hematot ...... essive non-Hodgkin's lymphoma.
@en
prefLabel
Prognostic factors for hematot ...... essive non-Hodgkin's lymphoma.
@ast
Prognostic factors for hematot ...... essive non-Hodgkin's lymphoma.
@en
P2093
P356
P1433
P1476
Prognostic factors for hematot ...... essive non-Hodgkin's lymphoma.
@en
P2093
German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
M Loeffler
M Pfreundschuh
P304
P356
10.1093/ANNONC/MDM541
P577
2007-11-28T00:00:00Z